Why the study?
What is the risk of developing second and third degree AV block in patients with sinus node disease treated with atrial pacing?
What is the risk of developing second and third degree AV block in patients with sinus node disease treated with atrial pacing?
Patients with sinus node disease treated with atrial pacing have a low risk of developing clinically important AV block, supporting the safety of this pacing strategy.
Supports atrial pacing safety in sinus node disease; confirms low AV block risk via Level 1 synthesis.
A literature survey was performed to establish the prevalence of second and third degree AV block among patients with permanent atrial pacemakers because of sinus node disease. This study reviews data from 28 different studies on atrial pacing with a median follow-up of 36 months. The collected data shows a median annual incidence of second and third degree AV block of 0.6%, range 0%-4.5% with a total prevalence of 2.1%, range 0%-11.9%. There was no significant difference in follow-up time between studies that showed a low, compared with a high incidence of AV-block. Patients with sinus node disease treated with atrial pacing have a low risk of developing clinically important conduction disturbances.
No takes yet. Share an insight, caveat, or question.
Rosenqvist et al. (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: